Multishield DC Intramammary Suspension
Country: United Kingdom
Language: English
Source: HMA (Heads of Medicines Agencies)
Summary of Product characteristics
(SPC)
07-04-2013
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
neomycin 100 mg, procaine 400 mg
Available from:
Cross Vetpharm Group
ATC code:
QJ51RC
Pharmaceutical form:
Intramammary suspension
Therapeutic group:
lactam antibacterials, penicillins, combinations with other antibacterials
Therapeutic area:
Cattle Food
Authorization date:
2012-12-21
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Multishield DC Intramammary Suspension for Cows.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.5g intramammary syringe contains
Active Substances:
Neomycin
70 000 IU
(corresponding to Neomycin Sulphate
100 mg)
Penethamate
77.2 mg
(corresponding to Penethamate Hydriodide
100 mg)
Benzylpenicillin
227.2 mg
(corresponding to Procaine Benzylpenicillin
400 mg)
Excipients:
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension.
A smooth, off white, oily suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cows (at dry off).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cows at drying off:
Treatment of subclinical mastitis caused by bovine mastitis organisms sensitive to the combination of active
substances, penicillin and neomycin, and as part of strategy for the prevention of new infections occurring during the
dry period.
4.3 CONTRAINDICATIONS
Do not use in lactating cows.
Do not use in animals which are known to be hypersensitive to
-lactam antibiotics, cephalosporin antibiotics,
neomycin or other aminoglycoside antibiotics or to iodine.
Do not use in cows with clinical mastitis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 29/01/2013_
_CRN 7010064_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not
possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria.
Official, national and regional antimicrobial p
Read the complete document
